A citation-based method for searching scientific literature

Calliope A Dendrou, Lars Fugger, Manuel A Friese. Nat Rev Immunol 2015
Times Cited: 1134







List of co-cited articles
875 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Multiple sclerosis.
Alan J Thompson, Sergio E Baranzini, Jeroen Geurts, Bernhard Hemmer, Olga Ciccarelli. Lancet 2018
797
16

Multiple Sclerosis: Mechanisms and Immunotherapy.
Clare Baecher-Allan, Belinda J Kaskow, Howard L Weiner. Neuron 2018
388
12

Multiple Sclerosis.
Daniel S Reich, Claudia F Lucchinetti, Peter A Calabresi. N Engl J Med 2018
987
11

Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis.
Tomas Olsson, Lisa F Barcellos, Lars Alfredsson. Nat Rev Neurol 2017
452
10

Reassessing B cell contributions in multiple sclerosis.
Rui Li, Kristina R Patterson, Amit Bar-Or. Nat Immunol 2018
187
9


Role of the innate and adaptive immune responses in the course of multiple sclerosis.
Bernhard Hemmer, Martin Kerschensteiner, Thomas Korn. Lancet Neurol 2015
316
9

Memory B Cells Activate Brain-Homing, Autoreactive CD4+ T Cells in Multiple Sclerosis.
Ivan Jelcic, Faiez Al Nimer, Jian Wang, Verena Lentsch, Raquel Planas, Ilijas Jelcic, Aleksandar Madjovski, Sabrina Ruhrmann, Wolfgang Faigle, Katrin Frauenknecht,[...]. Cell 2018
227
8

Multiple sclerosis.
Massimo Filippi, Amit Bar-Or, Fredrik Piehl, Paolo Preziosa, Alessandra Solari, Sandra Vukusic, Maria A Rocca. Nat Rev Dis Primers 2018
445
8

Multiple sclerosis.
Alastair Compston, Alasdair Coles. Lancet 2008
8

The relation between inflammation and neurodegeneration in multiple sclerosis brains.
Josa M Frischer, Stephan Bramow, Assunta Dal-Bianco, Claudia F Lucchinetti, Helmut Rauschka, Manfred Schmidbauer, Henning Laursen, Per Soelberg Sorensen, Hans Lassmann. Brain 2009
921
8

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis.
Xavier Montalban, Stephen L Hauser, Ludwig Kappos, Douglas L Arnold, Amit Bar-Or, Giancarlo Comi, Jérôme de Seze, Gavin Giovannoni, Hans-Peter Hartung, Bernhard Hemmer,[...]. N Engl J Med 2017
892
8

B and T Cells Driving Multiple Sclerosis: Identity, Mechanisms and Potential Triggers.
Jamie van Langelaar, Liza Rijvers, Joost Smolders, Marvin M van Luijn. Front Immunol 2020
74
10

Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS).
Cris S Constantinescu, Nasr Farooqi, Kate O'Brien, Bruno Gran. Br J Pharmacol 2011
766
8


Multiple sclerosis: experimental models and reality.
Hans Lassmann, Monika Bradl. Acta Neuropathol 2017
270
8

Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses.
Lazaros Belbasis, Vanesa Bellou, Evangelos Evangelou, John P A Ioannidis, Ioanna Tzoulaki. Lancet Neurol 2015
374
7

B-cell depletion with rituximab in relapsing-remitting multiple sclerosis.
Stephen L Hauser, Emmanuelle Waubant, Douglas L Arnold, Timothy Vollmer, Jack Antel, Robert J Fox, Amit Bar-Or, Michael Panzara, Neena Sarkar, Sunil Agarwal,[...]. N Engl J Med 2008
7

Alterations of the human gut microbiome in multiple sclerosis.
Sushrut Jangi, Roopali Gandhi, Laura M Cox, Ning Li, Felipe von Glehn, Raymond Yan, Bonny Patel, Maria Antonietta Mazzola, Shirong Liu, Bonnie L Glanz,[...]. Nat Commun 2016
653
7

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis.
Chris H Polman, Paul W O'Connor, Eva Havrdova, Michael Hutchinson, Ludwig Kappos, David H Miller, J Theodore Phillips, Fred D Lublin, Gavin Giovannoni, Andrzej Wajgt,[...]. N Engl J Med 2006
7

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria.
Alan J Thompson, Brenda L Banwell, Frederik Barkhof, William M Carroll, Timothy Coetzee, Giancarlo Comi, Jorge Correale, Franz Fazekas, Massimo Filippi, Mark S Freedman,[...]. Lancet Neurol 2018
7

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis.
Stephen Sawcer, Garrett Hellenthal, Matti Pirinen, Chris C A Spencer, Nikolaos A Patsopoulos, Loukas Moutsianas, Alexander Dilthey, Zhan Su, Colin Freeman, Sarah E Hunt,[...]. Nature 2011
7

Progressive multiple sclerosis: from pathophysiology to therapeutic strategies.
Simon Faissner, Jason R Plemel, Ralf Gold, V Wee Yong. Nat Rev Drug Discov 2019
169
7

Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolution.
Takahiro Masuda, Roman Sankowski, Ori Staszewski, Chotima Böttcher, Lukas Amann, Sagar, Christian Scheiwe, Stefan Nessler, Patrik Kunz, Geert van Loo,[...]. Nature 2019
492
7

Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition.
Clare Walton, Rachel King, Lindsay Rechtman, Wendy Kaye, Emmanuelle Leray, Ruth Ann Marrie, Neil Robertson, Nicholas La Rocca, Bernard Uitdehaag, Ingrid van der Mei,[...]. Mult Scler 2020
289
7

C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE.
Andrea Reboldi, Caroline Coisne, Dirk Baumjohann, Federica Benvenuto, Denise Bottinelli, Sergio Lira, Antonio Uccelli, Antonio Lanzavecchia, Britta Engelhardt, Federica Sallusto. Nat Immunol 2009
818
7

Functional inflammatory profiles distinguish myelin-reactive T cells from patients with multiple sclerosis.
Yonghao Cao, Brittany A Goods, Khadir Raddassi, Gerald T Nepom, William W Kwok, J Christopher Love, David A Hafler. Sci Transl Med 2015
201
7

Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis.
Vissia Viglietta, Clare Baecher-Allan, Howard L Weiner, David A Hafler. J Exp Med 2004
7

Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology.
Roberta Magliozzi, Owain Howell, Abhilash Vora, Barbara Serafini, Richard Nicholas, Maria Puopolo, Richard Reynolds, Francesca Aloisi. Brain 2007
916
6

Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis.
Manuel A Friese, Benjamin Schattling, Lars Fugger. Nat Rev Neurol 2014
364
6

Neuronal vulnerability and multilineage diversity in multiple sclerosis.
Lucas Schirmer, Dmitry Velmeshev, Staffan Holmqvist, Max Kaufmann, Sebastian Werneburg, Diane Jung, Stephanie Vistnes, John H Stockley, Adam Young, Maike Steindel,[...]. Nature 2019
193
6

Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice.
Kerstin Berer, Lisa Ann Gerdes, Egle Cekanaviciute, Xiaoming Jia, Liang Xiao, Zhongkui Xia, Chuan Liu, Luisa Klotz, Uta Stauffer, Sergio E Baranzini,[...]. Proc Natl Acad Sci U S A 2017
435
6

Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models.
Egle Cekanaviciute, Bryan B Yoo, Tessel F Runia, Justine W Debelius, Sneha Singh, Charlotte A Nelson, Rachel Kanner, Yadira Bencosme, Yun Kyung Lee, Stephen L Hauser,[...]. Proc Natl Acad Sci U S A 2017
450
6

Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls.
Jun Chen, Nicholas Chia, Krishna R Kalari, Janet Z Yao, Martina Novotna, M Mateo Paz Soldan, David H Luckey, Eric V Marietta, Patricio R Jeraldo, Xianfeng Chen,[...]. Sci Rep 2016
472
6

Ofatumumab versus Teriflunomide in Multiple Sclerosis.
Stephen L Hauser, Amit Bar-Or, Jeffrey A Cohen, Giancarlo Comi, Jorge Correale, Patricia K Coyle, Anne H Cross, Jerome de Seze, David Leppert, Xavier Montalban,[...]. N Engl J Med 2020
169
6

Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor.
Veit Rothhammer, Ivan D Mascanfroni, Lukas Bunse, Maisa C Takenaka, Jessica E Kenison, Lior Mayo, Chun-Cheih Chao, Bonny Patel, Raymond Yan, Manon Blain,[...]. Nat Med 2016
668
6

Differential roles of microglia and monocytes in the inflamed central nervous system.
Ryo Yamasaki, Haiyan Lu, Oleg Butovsky, Nobuhiko Ohno, Anna M Rietsch, Ron Cialic, Pauline M Wu, Camille E Doykan, Jessica Lin, Anne C Cotleur,[...]. J Exp Med 2014
542
6

Immunology of Multiple Sclerosis.
Mireia Sospedra, Roland Martin. Semin Neurol 2016
120
6

HLA-DR15 Molecules Jointly Shape an Autoreactive T Cell Repertoire in Multiple Sclerosis.
Jian Wang, Ivan Jelcic, Lena Mühlenbruch, Veronika Haunerdinger, Nora C Toussaint, Yingdong Zhao, Carolina Cruciani, Wolfgang Faigle, Reza Naghavian, Magdalena Foege,[...]. Cell 2020
66
9

Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis.
Ashley H Beecham, Nikolaos A Patsopoulos, Dionysia K Xifara, Mary F Davis, Anu Kemppinen, Chris Cotsapas, Tejas S Shah, Chris Spencer, David Booth, An Goris,[...]. Nat Genet 2013
890
6

Progressive multiple sclerosis: from pathogenic mechanisms to treatment.
Jorge Correale, María I Gaitán, María C Ysrraelit, Marcela P Fiol. Brain 2017
266
6

Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination.
Kerstin Berer, Marsilius Mues, Michail Koutrolos, Zakeya Al Rasbi, Marina Boziki, Caroline Johner, Hartmut Wekerle, Gurumoorthy Krishnamoorthy. Nature 2011
789
5

The compartmentalized inflammatory response in the multiple sclerosis brain is composed of tissue-resident CD8+ T lymphocytes and B cells.
Joana Machado-Santos, Etsuji Saji, Anna R Tröscher, Manuela Paunovic, Roland Liblau, Galina Gabriely, Christian G Bien, Jan Bauer, Hans Lassmann. Brain 2018
232
5

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination.
C Lucchinetti, W Brück, J Parisi, B Scheithauer, M Rodriguez, H Lassmann. Ann Neurol 2000
5

B cells in multiple sclerosis - from targeted depletion to immune reconstitution therapies.
Maria T Cencioni, Miriam Mattoscio, Roberta Magliozzi, Amit Bar-Or, Paolo A Muraro. Nat Rev Neurol 2021
44
11

Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation.
Hania Kebir, Katharina Kreymborg, Igal Ifergan, Aurore Dodelet-Devillers, Romain Cayrol, Monique Bernard, Fabrizio Giuliani, Nathalie Arbour, Burkhard Becher, Alexandre Prat. Nat Med 2007
5

Role of the microbiota in immunity and inflammation.
Yasmine Belkaid, Timothy W Hand. Cell 2014
5

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study.
Ludwig Kappos, Amit Bar-Or, Bruce A C Cree, Robert J Fox, Gavin Giovannoni, Ralf Gold, Patrick Vermersch, Douglas L Arnold, Sophie Arnould, Tatiana Scherz,[...]. Lancet 2018
437
5

Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation.
Lior Mayo, Sunia A Trauger, Manon Blain, Meghan Nadeau, Bonny Patel, Jorge I Alvarez, Ivan D Mascanfroni, Ada Yeste, Pia Kivisäkk, Keith Kallas,[...]. Nat Med 2014
273
5

Myelin impairs CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation.
Mark R Kotter, Wen-Wu Li, Chao Zhao, Robin J M Franklin. J Neurosci 2006
471
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.